Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model

Modern Pathology

Volumn 19, Issue 3, 2006, Pages 407-416

  Willems, Stefan M ^a   Debiec Rychter, Maria ^b   Szuhai, Károly ^a   Hogendoorn, Pancras C W ^a   Sciot, Raphaël ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cytogenetics; Imbalances; Myxofibrosarcoma; Myxoid malignant fibrous histiocytoma; Ring chromosomes; Soft tissue tumours

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROMYXOSARCOMA; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPE; MALE; MEDICAL LITERATURE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; DISEASE PROGRESSION; FEMALE; FIBROSARCOMA; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SPECTRAL KARYOTYPING;

EID: 33244498017     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800550     Document Type: Article

References (37)

1. Angervall L, Kindblom LG, Merck C. Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand [A] 1977;85A:127-140.
2. Mentzel T, Van den Berg E, Molenaar WM. Myxofibrosarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds). World Health Organization classification of tumours. pathology and genetics. Tumours of soft tissue and bone, 2002 edn. IARC press: Lyon, 2004, pp 102-103.
3. Weiss SW, Enzinger FM. Myxoid vaiant of malignant fibrous histiocytoma. Cancer 1977;39:1672-1685.
4. Mentzel T, Calonje E, Wadden C, et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996;20:391-405.
5. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42.
6. Limon J, Dal Cin P, Sandberg AA. Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 1986;23:305-313.
7. ISCN. An international system for human cytogenetic nomenclature. S.Karger: Basel, 1995.
8. Szuhai K, Knijnenburg J, Ijszenga M, et al. Multicolor fluorescence in situ hybridization analysis of a synovial sarcoma of the larynx with a t(X;18)(p11.2;q11.2) and trisomies 2 and 8. Cancer Genet Cytogenet 2004;153:48-52.
9. Tanke HJ, Wiegant J, Van Gijlswijk RPM, et al. New strategy for multi-colour fluorescence in situ hybrydisation: COBRA: COmbined Binary RAtio labelling. Eur J Hum Genet 1999;7:2-11.
10. Wiegant J, Bezrookove V, Rosenberg C, et al. Differentially painting human chromosome arms with combined binary ratio-labeling fluorescence in situ hybridization. Genome Res 2000;10:861-865.
11. Mertens F, Fletcher CD, Dal Cin P, et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology. Genes Chromosomes Cancer 1998;22:16-25.
12. Graadt van Roggen JF, Hogendoorn PCW, Fletcher CDM. Myxoid tumours of soft tissue. Histopathology 1999;35:291-312.
13. Clawson K, Donner LR, Dobin SM. Translocation (2;15)(p23;q21.2) and interstitial deletion of 7q in a case of low-grade myxofibrosarcoma. Cancer Genet Cytogenet 2001;127:140-142.
14. Johansson M, Karauzum SB, Dietrich C, et al. Karyotypic abnormalities in adenocarcinomas of the lung. Int J Oncol 1994;5:17-26.
15. Mandahl N, Heim S, Willén H, et al. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosomes Cancer 1989;1:9-14.
16. Meis-Kindblom JM, Sjogren H, Kindblom LG, et al. Cytogenetic and molecular analyses of liposarcoma and its soft tissue simulators: recognition of new variants of differential diagnosis. Virchows Arch 2001;439:141-151.
17. Meloni-Ehrig AM, Chen Z, Guan XY, et al. Identification of a ring chromosome in a myxoid malignant fibrous histiocytoma with chromosome microdissection and fluorescence in situ hybridization. Cancer Genet Cytogenet 1999;109:81-85.
18. Mertens F, Larramendy M, Gustavsson A, et al. Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p. Cancer Genet Cytogenet 2000;116:89-96.
19. Nilsson M, Meza-Zepeda LA, Mertens F, et al. Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer 2004;109:363-369.
20. Simons A, Schepens M, Jeuken J, et al. Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 2000;118:89-98.
21. Szymanska J, Tarkkanen M, Wiklund T, et al. A cytogenetic study of malignant fibrous histiocytoma. Cancer Genet Cytogenet 1995;85:91-96.
22. Orndal C, Mandahl N, Rydholm A, et al. Supernumerary ring chromosomes in 5 bone and soft-tissue tumors of low Or borderline malignancy. Cancer Genet Cytogenet 1992;60:170-175.
23. Orndal C, Mandahl N, Willen H, et al. Cytogenetic evolution in primary tumors, local recurrences, and pulmonary metastases of 2 soft-tissue sarcomas. Clin Exp Metast 1993;11:401-408.
24. Orndal C, Rydholm A, Willen H, et al. Cytogenetic intratumor heterogeneity in soft-tissue tumors. Cancer Genet Cytogenet 1994;78:127-137.
25. Huang HY, Lal P, Qin J, et al. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol 2004;35:612-621.
26. Merck C, Angervall L, Kindblom LG, et al. Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand Suppl 1983;282:1-40.
27. Ferguson PC, Deshmukh N, Abudu A, et al. Change in histological grade in locally recurrent soft tissue sarcomas. Eur J Cancer 2004;40:2237-2242.
28. Dei Tos AP, Doglioni C, Piccinin S, et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 2000;190:531-536.
29. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000;157:377-384.
30. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997;15(Spec No):417-474.
31. Mandahl N, Heim S, Arheden K, et al. Multiple karyotypic rearrangements, including t(X;18)(p11;q11), in a fibrosarcoma. Cancer Genet Cytogenet 1988;30:323-327.
32. Mandahl N, Heim S, Arheden K, et al. Separate karyotypic features in a local recurrence and a metastasis of a fibrosarcoma. Cancer Genet Cytogenet 1989;37:139-140.
33. Weng WH, Ahlen J, Lui WO, et al. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. Br J Cancer 2003;89:720-726.
34. Martignetti JA, Gelb BD, Pierce H, et al. Malignant fibrous histiocytoma: inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22-evidence for a common genetic defect. Genes Chromosomes Cancer 2000;27:191-195.
35. Weil D, Mattel MG, Passage E, et al. Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. Am J Hum Genet 1988;42:435-445.
36. Hornick JL, Bosenberg MW, Mentzel T, et al. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol 2004;28:1257-1267.
37. Idbaih A, Coindre JM, Derre J, et al. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 2005;85:176-181.